Many healthy people have immunity from vaccines and previous infection. This is a KFF Health News story. The U.S. Food and Drug Administration has approved an updated COVID-19 shot for everyone 6 ...
Amid an ongoing surge, the U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines for the 2024-2025 respiratory disease season. The new shots, made by Moderna and Pfizer ...
Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...
Millions of updated COVID-19 vaccines will soon be ready for patients following Food and Drug Administration approval announced on Thursday. The updated vaccines from Pfizer and Moderna for people ...
Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.
The FDA has authorized Novavax's new formula, adding to a repertoire of revamped COVID vaccines. Here's what to know about cost and more. Jessica Rendall Wellness Reporter Jessica is a writer on ...
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully ...
CORRECTION: An earlier version of this story misstated the number of RSV vaccines approved for older adults. There are three vaccines. The pools are closing, the kids are back in school and ...
The Food and Drug Administration has approved updated COVID-19 vaccines to protect against currently circulating variants, and the shots have shown to be more effective than the now-available ...
In early 2022, I cared for one of the first patients with mpox in Massachusetts. As an infectious diseases physician, I remember the deep uncertainty I felt, and the fear in my patient’s eyes as ...
The vaccines target the KP.2 strain, an offshoot of the omicron variant. The U.S. Food and Drug Administration approved and granted emergency use authorization Thursday for updated COVID-19 ...